|
1
|
You JR, Chen YT, Hsieh CY, Chen SY, Lin TY, Shih JS, Chen GT, Feng SW, Peng TY, Wu CY, Lee IT. Exploring Possible Diagnostic Precancerous Biomarkers for Oral Submucous Fibrosis: A Narrative Review. Cancers (Basel) 2023; 15:4812. [PMID: 37835505 PMCID: PMC10571555 DOI: 10.3390/cancers15194812] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2023] [Revised: 09/27/2023] [Accepted: 09/28/2023] [Indexed: 10/15/2023] Open
Abstract
Oral submucous fibrosis (OSF) stands as a progressive oral ailment, designated as a potentially malignant disorder. OSF has gained widespread recognition as a significant precursor to malignant transformation. In the pursuit of dependable, straightforward, and non-invasive diagnostic measures for the early detection of oral malignant progression, research has delved into potential diagnostic biomarkers of OSF. This comprehensive review delves into current investigations that explore the correlation between various biomarkers and OSF. The molecular biomarkers of OSF are categorized based on cytology and sampling methods. Moreover, this review encompasses pertinent studies detailing how these biomarkers are acquired and processed. Within this scope, we scrutinize four potential biomarkers that hold the promise of facilitating the development of diagnostic tools for detecting early-stage OSF.
Collapse
Affiliation(s)
- Jie-Ru You
- School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei 110301, Taiwan; (J.-R.Y.); (Y.-T.C.); (C.-Y.H.); (S.-Y.C.); (T.-Y.L.); (J.-S.S.); (G.-T.C.); (S.-W.F.); (T.-Y.P.)
| | - Ya-Ting Chen
- School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei 110301, Taiwan; (J.-R.Y.); (Y.-T.C.); (C.-Y.H.); (S.-Y.C.); (T.-Y.L.); (J.-S.S.); (G.-T.C.); (S.-W.F.); (T.-Y.P.)
| | - Chia-Yu Hsieh
- School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei 110301, Taiwan; (J.-R.Y.); (Y.-T.C.); (C.-Y.H.); (S.-Y.C.); (T.-Y.L.); (J.-S.S.); (G.-T.C.); (S.-W.F.); (T.-Y.P.)
| | - Sin-Yu Chen
- School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei 110301, Taiwan; (J.-R.Y.); (Y.-T.C.); (C.-Y.H.); (S.-Y.C.); (T.-Y.L.); (J.-S.S.); (G.-T.C.); (S.-W.F.); (T.-Y.P.)
| | - Tzu-Yao Lin
- School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei 110301, Taiwan; (J.-R.Y.); (Y.-T.C.); (C.-Y.H.); (S.-Y.C.); (T.-Y.L.); (J.-S.S.); (G.-T.C.); (S.-W.F.); (T.-Y.P.)
| | - Jing-Syuan Shih
- School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei 110301, Taiwan; (J.-R.Y.); (Y.-T.C.); (C.-Y.H.); (S.-Y.C.); (T.-Y.L.); (J.-S.S.); (G.-T.C.); (S.-W.F.); (T.-Y.P.)
| | - Guan-Ting Chen
- School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei 110301, Taiwan; (J.-R.Y.); (Y.-T.C.); (C.-Y.H.); (S.-Y.C.); (T.-Y.L.); (J.-S.S.); (G.-T.C.); (S.-W.F.); (T.-Y.P.)
| | - Sheng-Wei Feng
- School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei 110301, Taiwan; (J.-R.Y.); (Y.-T.C.); (C.-Y.H.); (S.-Y.C.); (T.-Y.L.); (J.-S.S.); (G.-T.C.); (S.-W.F.); (T.-Y.P.)
| | - Tzu-Yu Peng
- School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei 110301, Taiwan; (J.-R.Y.); (Y.-T.C.); (C.-Y.H.); (S.-Y.C.); (T.-Y.L.); (J.-S.S.); (G.-T.C.); (S.-W.F.); (T.-Y.P.)
| | - Chia-Yu Wu
- Division of Oral and Maxillofacial Surgery, Department of Dentistry, Taipei Medical University Hospital, Taipei 11031, Taiwan
- School of Dental Technology, College of Oral Medicine, Taipei Medical University, Taipei 11031, Taiwan
| | - I-Ta Lee
- School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei 110301, Taiwan; (J.-R.Y.); (Y.-T.C.); (C.-Y.H.); (S.-Y.C.); (T.-Y.L.); (J.-S.S.); (G.-T.C.); (S.-W.F.); (T.-Y.P.)
| |
Collapse
|
|
2
|
Singh AG, Roy S, Oza S, Singhavi H, Chatterjee K, Chaturvedi P. A contemporary narrative review to guide molecular epidemiology of oral submucous fibrosis. INTERNATIONAL JOURNAL OF MOLECULAR EPIDEMIOLOGY AND GENETICS 2021; 12:61-70. [PMID: 34552689 PMCID: PMC8449189] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 05/31/2021] [Accepted: 08/09/2021] [Indexed: 06/13/2023]
Abstract
Oral submucous Fibrosis (OSMF) is a chronic disease that mainly affects the upper part of the aerodigestive tract. Areca nut and betel quid chewing has been established as the most significant causative factor for this condition. While OSMF is a predominantly Asian disease, the migrant populations from the region have taken the disease across the globe. Additionally, areca nut is now easily accessible in flavors and aggressively marketed. Many research activities have been undertaken for decades to understand the etiopathogenesis and risk factors of OSMF. Although OSMF is a slowly progressing disease, it has the potential to transform to an oral malignancy. This article is an attempt to review the literature and provide an update on its prevalence, etiopthogenesis and its diagnosis. We also highlight certain clinical, histopathological and molecular features that aid in the diagnosis and prognostication of OSMF, highlighting the importance of identifying the possibly high risk OSMF that is prone to malignant transformation. Using this information, future directions can be developed to include treatmentof OSMF through a dynamic gene-specific approach.
Collapse
|
|
3
|
Shen YW, Shih YH, Fuh LJ, Shieh TM. Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and Treatments. Int J Mol Sci 2020; 21:ijms21197231. [PMID: 33008091 PMCID: PMC7582467 DOI: 10.3390/ijms21197231] [Citation(s) in RCA: 64] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2020] [Revised: 09/24/2020] [Accepted: 09/26/2020] [Indexed: 02/07/2023] Open
Abstract
Oral submucous fibrosis (OSF) is a collagen deposition disorder that affects a patient’s oral function and quality of life. It may also potentially transform into malignancy. This review summarizes the risk factors, pathogenic mechanisms, and treatments of OSF based on clinical and bio-molecular evidence. Betel nut chewing is a major risk factor that causes OSF in Asia. However, no direct evidence of arecoline-induced carcinogenesis has been found in animal models. Despite identification of numerous biomarkers of OSF lesions and conducting trials with different drug combinations, clinicians still adopt conservative treatments that primarily focus on relieving the symptoms of OSF. Treatments focus on reducing inflammation and improving mouth opening to improve a patient’s quality of life. In conclusion, high-quality clinical studies are needed to aid clinicians in developing and applying molecular biomarkers as well as standard treatment guidelines.
Collapse
Affiliation(s)
- Yen-Wen Shen
- School of Dentistry, China Medical University, Taichung 40402, Taiwan;
- Department of Dentistry, China Medical University Hospital, Taichung City 404332, Taiwan
| | - Yin-Hwa Shih
- Department of Healthcare Administration, Asia University, Taichung 41354, Taiwan;
| | - Lih-Jyh Fuh
- School of Dentistry, China Medical University, Taichung 40402, Taiwan;
- Department of Dentistry, China Medical University Hospital, Taichung City 404332, Taiwan
- Correspondence: (L.-J.F.); (T.-M.S.); Tel.: +88-642-205-3366 (ext. 2312) (L.-J.F.); +88-642-205-3366 (ext. 7707) (T.-M.S.)
| | - Tzong-Ming Shieh
- School of Dentistry, China Medical University, Taichung 40402, Taiwan;
- Department of Dental Hygiene, China Medical University, Taichung 40402, Taiwan
- Correspondence: (L.-J.F.); (T.-M.S.); Tel.: +88-642-205-3366 (ext. 2312) (L.-J.F.); +88-642-205-3366 (ext. 7707) (T.-M.S.)
| |
Collapse
|
|
4
|
Oral Submucous Fibrosis: A Review on Etiopathogenesis, Diagnosis, and Therapy. Int J Mol Sci 2019; 20:ijms20122940. [PMID: 31208114 PMCID: PMC6627879 DOI: 10.3390/ijms20122940] [Citation(s) in RCA: 120] [Impact Index Per Article: 24.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2019] [Revised: 06/10/2019] [Accepted: 06/14/2019] [Indexed: 12/24/2022] Open
Abstract
Oral submucous fibrosis (OSF) is characterized by abnormal collagen deposition. It is a precancerous disorder and transforms into a malignant tumor in 1.5–15% of all cases. Symptoms include submucous fibrosis, ulceration, xerostomia, a burning sensation, and restricted mouth opening. All of these greatly interfere with patient quality of life. The present review introduces OSF from a molecular perspective and summarizes what is known about its underlying mechanisms, diagnostic biomarkers, and therapeutic interventions. In addition to the aggressive treatment of OSF, its prevention is also important. Future research should, therefore, focus on improving the oral health literacy of the patients susceptible to OSF.
Collapse
|